首页> 外国专利> DELAYED RELEASE ORAL FORMULATION FOR ENHANCED INTESTINAL OLIGONUCLEOTIDE ABSORPTION

DELAYED RELEASE ORAL FORMULATION FOR ENHANCED INTESTINAL OLIGONUCLEOTIDE ABSORPTION

机译:延迟释放口服制剂增强肠内寡核苷酸的吸收

摘要

Delayed release oral pharmaceutical formulations and methods for enhanced intestinal drug absorption. The formulation comprises a first population of carrier particles comprising a drug and a penetration enhancer which are released at a first location in the intestine, and a second population of carrier particles comprising a penetration enhancer and a delayed release coating or matrix. This penetration enhancer is released at a second location in the intestine downstream from the first location and enhances absorption of the drug when it reaches the second location.
机译:延迟释放的口服药物制剂和增强肠道药物吸收的方法。该制剂包括在肠道中的第一位置释放的包含药物和渗透促进剂的第一载体颗粒群,和包含渗透促进剂和延迟释放包衣或基质的第二载体颗粒。该渗透促进剂在肠道中位于第一位置下游的第二位置处释放,并在到达第二位置时增强药物的吸收。

著录项

  • 公开/公告号IL160117A

    专利类型

  • 公开/公告日2013-03-24

    原文格式PDF

  • 申请/专利权人 ISIS PHARMACEUTICALS INC.;

    申请/专利号IL20040160117

  • 发明设计人

    申请日2004-01-29

  • 分类号A61K47/12;A61K9/20;A61K9/22;A61K9/24;A61K9/26;A61K9/28;A61K9/42;A61K9/48;A61K9/52;A61K9/54;A61K9/66;A61K31/7088;A61K38;A61K39;A61K39/395;A61K47/04;A61K47/08;A61K47/14;A61K47/16;A61K47/18;A61K47/22;A61K47/26;A61K47/28;A61K47/32;A61K47/34;A61K47/36;A61K47/38;A61K47/42;A61K48;A61P1/04;A61P19/02;A61P29;A61P35;A61P43;

  • 国家 IL

  • 入库时间 2022-08-21 16:41:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号